Marisa Cressatti

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort.

Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort.

Journal: Journal of Parkinson's disease
Published: September 20, 2024

Development and internal validation of a prognostic model for loss of balance and falls in mid- to late-stage Parkinson's disease.

Development and internal validation of a prognostic model for loss of balance and falls in mid- to late-stage Parkinson's disease.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 25, 2023

Dysregulation of a Heme Oxygenase-Synuclein Axis in Parkinson Disease.

Dysregulation of a Heme Oxygenase-Synuclein Axis in Parkinson Disease.

Journal: NeuroSci
Published: March 31, 2022

Salivary Heme Oxygenase-1: A Potential Biomarker for Central Neurodegeneration.

Salivary Heme Oxygenase-1: A Potential Biomarker for Central Neurodegeneration.

Journal: Journal of central nervous system disease
Published: February 13, 2021

Characterization and heme oxygenase-1 content of extracellular vesicles in human biofluids.

Characterization and heme oxygenase-1 content of extracellular vesicles in human biofluids.

Journal: Journal of neurochemistry
Published: May 19, 2020

Strategic Timing of Glial HMOX1 Expression Results in Either Schizophrenia-Like or Parkinsonian Behavior in Mice.

Strategic Timing of Glial HMOX1 Expression Results in Either Schizophrenia-Like or Parkinsonian Behavior in Mice.

Journal: Antioxidants & redox signaling
Published: December 19, 2019

Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease.

Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: July 05, 2019

Glial HMOX1 expression promotes central and peripheral α-synuclein dysregulation and pathogenicity in parkinsonian mice.

Glial HMOX1 expression promotes central and peripheral α-synuclein dysregulation and pathogenicity in parkinsonian mice.

Journal: Glia
Published: November 06, 2018

The sinister face of heme oxygenase-1 in brain aging and disease.

The sinister face of heme oxygenase-1 in brain aging and disease.

Journal: Progress in neurobiology
Published: March 27, 2018

Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease.

Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: July 24, 2017

Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment.

Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment.

Journal: Neurobiology of aging
Published: February 02, 2017

Cysteine-rich whey protein isolate (Immunocal®) ameliorates deficits in the GFAP.HMOX1 mouse model of schizophrenia.

Cysteine-rich whey protein isolate (Immunocal®) ameliorates deficits in the GFAP.HMOX1 mouse model of schizophrenia.

Journal: Free radical biology & medicine
Published: December 15, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026